Results 231 to 240 of about 561,328 (285)

Methotrexate‐Loaded Liposomal Formulation Enables 6‐Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 1, 9 January 2026.
A liposomal formulation for methotrexate enables minimally invasive, sustained intraocular drug delivery for over six weeks with a single injection. Developed for treating intraocular diseases like lymphoma and PVR, it offers excellent biocompatibility in vivo in a porcine model.
Maximilian Hammer   +17 more
wiley   +1 more source

Development and validation of RP-HPLC method for the estimation of Erlotinib in pharmaceutical formulation

open access: yes, 2017
S. Latha   +5 more
semanticscholar   +1 more source

Cryptocyanine‐Based Fluorescent Probes for DNA Detection: Controlling Solubility and Aggregation Through Side Chain Design

open access: yesAdvanced Sensor Research, Volume 5, Issue 1, January 2026.
Cryptocyanine‐based fluorogenic DNA probes with improved water solubility and reduced aggregation were developed by tuning side‐chain polarity. The derivatives exhibit high fluorescence enhancement upon DNA binding, highlighting their potential as environment‐sensitive tools for nucleic acid detection and bioanalytical applications.
Farkas Domahidy   +6 more
wiley   +1 more source

Development and validation of Ketorolac Tromethamine in eye drop formulation by RP-HPLC method

open access: yes, 2017
G. Sunil   +5 more
semanticscholar   +1 more source

MMP2‐Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti‐Cancer Drugs in Treating Melanoma

open access: yesAdvanced Therapeutics, Volume 9, Issue 1, January 2026.
A bi‐functional liposomal system is developed to enhance melanoma therapy, combining mApoE‐mediated targeting of LDLR‐expressing tumor cells with MMP2‐responsive drug release. Loaded with Pimasertib, the liposomes improve intracellular delivery, reduce melanoma viability, and inhibit 3D spheroid growth and invasiveness.
Antonio Renda   +14 more
wiley   +1 more source

Improved Rp- Hplc Method for the Simultaneous Estimation of Tranexamic Acid and Mefenamic Acid in Tablet Dosage Form

open access: hybrid, 2011
Subramanian Natesan   +3 more
openalex   +1 more source

In Situ Engineering of Tumor Cells as Self‐Sustaining cDC1 Programming Factories for Effective Cancer Immunotherapy

open access: yesAdvanced Science, Volume 13, Issue 4, 19 January 2026.
The fused EV platform AS16‐EL@MPLA/p‐FX reprograms tumor cells into cytokine‐producing factories that continuously secrete XCL1 and FLT3L to recruit and differentiate cDC1s, while embedded MPLA activates them through TLR4 signaling and AS16 prevents their exhaustion, thereby enhancing antitumor immunity and establishing durable immune memory against ...
Shuiling Jin   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy